The data is in, and savvy pharma execs see that supporting patient engagement is not only a growing strategic initiative for pharma companies but is proving to be an impactful value driver.

Now pharma organizations know what their investment could generate in terms of financial benefits and clinical outcomes.

This webinar covers:
– The five major impacts that digital drug companions deliver for pharma;
– The real-world evidence and sources that validate the numbers;
– How competitors and execs are already valuing the digital drug companion market